New Studies Reestablishing Safety of HRT & Launch of Safer Drugs to Drive Growth of the Global HRT Market Amidst Challenges Posed by Widespread Off-Label Prescriptions
Revised studies re-establishing the health benefits and safety of hormone therapy, launch of new and safer drugs, and increasing demand for bioequivalent drugs are poised to drive the global market for Hormone Replacement Therapy (HRT) to reach US$10.7 billion by 2024 . Hormone Replacement Therapy (HRT), also known as Menopausal Hormone Therapy (MHT), refers to administration of [ estrogen ] hormones to female patients for replenishing declining natural hormone levels due to menopause. Menopause happens during the age of 45 to 55 years on average in women, when ovaries stop producing estrogens and menstruation stops. Major menopausal symptoms include hot flashes and night sweating, heart palpitations/anxiety, and genital dryness, all caused due to drop in the estrogen hormonal levels. About 75% of menopausal women experience these symptoms. Hormonal Replacement Therapy (HRT) refers to administration of natural or synthetic estrogens, either alone or in combination with proge...